A61P 7 - Drugs for disorders of the blood or the extracellular fluid

Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
11/2002
11/06/2002	EP1254898A1 Benzene-fused heterocycle derivatives and drugs containing the same as the active ingredient
11/06/2002	EP1254270A1 Methods and materials relating to cub domain polypeptides and polynucleotides
11/06/2002	EP1254268A1 Methods and materials relating to leucine-rich repeat protein-like (lrr protein-like) polypeptides and polynucleotides
11/06/2002	EP1254266A1 Methods and materials relating to alpha-2-macroglobulin-like polypeptides and polynucleotides
11/06/2002	EP1254255A1 Trefoil domain-containing polynucleotides, polypeptides, and antibodies
11/06/2002	EP1254246A1 Methods and materials relating to transforming growth factor alpha-like polypeptides and polynucleotides
11/06/2002	EP1254235A2 Drug metabolizing enzymes
11/06/2002	EP1254212A2 Methods of preparing and using a viral vector library
11/06/2002	EP1254159A2 Process for the preparation of acetyl-amidiniophenylalanyl-cyclohexylglycyl-pyridinioalaninamides
11/06/2002	EP1254136A1 FACTOR Xa INHIBITORS WITH ARYL-AMIDINES AND DERIVATIVES, AND PRODRUGS THEREOF
11/06/2002	EP1254133A2 Indol-3-yl derivatives
11/06/2002	EP1254132A1 Food product and process
11/06/2002	EP1254123A1 2-benzothiazolyl urea derivatives and their use as protein kinase inhibitors
11/06/2002	EP1254116A1 Alpha v integrin receptor antagonists
11/06/2002	EP1254114A2 Melanocortin receptor agonists and antagonists
11/06/2002	EP1253937A2 Methods of therapy with thrombin derived peptides
11/06/2002	EP1253917A2 Use of substituted 4-amino-1-phenylbutan-2-ol compounds as medicaments
11/06/2002	EP1157024B1 Acetylenic ortho-sulfonamido and phosphinic acid amido bicyclic heteroaryl hydroxamic acids as tace inhibitors
11/06/2002	EP1097159B1 Phosphinous and phosphonic acid derivatives used as medicaments
11/06/2002	EP0888386B1 Stable factor viii/ von willebrand factor complex
11/06/2002	CN1378552A Novel transcription factor BP1
11/06/2002	CN1378544A Substituted azoles compounds
11/06/2002	CN1378541A Inhibitors of c-JUN N-terminal kinase (JNK) and other protein kinases
11/06/2002	CN1378537A 嘧啶衍生物 Pyrimidine derivatives
11/06/2002	CN1378535A 四氢喹啉衍生物 Tetrahydroquinoline derivative
11/06/2002	CN1378534A Substituted polycyclic aryl and heteroaryl pyridones useful for selective inhibition of coagulation cascade
11/06/2002	CN1378531A Substituted pyrolidine-2,3,4-trion-3-oxime derivatives useful as NMDA receptor antagonists
11/06/2002	CN1378472A Synergy between low molecular weight heparin and platelet aggregation inhibitor, providing combination therapy for prevention and treatment of various thromboembolic disorders
11/06/2002	CN1378459A Treatment of auto immune diseases with antagonists which bind to B cell surface markers
11/06/2002	CN1378449A Iron chelators and use thereof
11/06/2002	CN1378448A Torsemide polymorphs
11/06/2002	CN1378445A Drug releasing biodegradable fiber implant
11/06/2002	CN1378443A Cationic liposome delivery of taxanes to angiogenic blood vessels
11/06/2002	CN1377893A Interleukin 11 analog
11/06/2002	CN1377891A Zinc finger protein from dendritic cell, its coding sequence and use
11/06/2002	CN1377689A Traditional Chinese medicine injection for curing cardiovascular and cerebrovascular diseases and fundus disease and its preparing method
11/06/2002	CN1093856C Substituted sulfonic acid N-[(aminoiminomethyl)phenylalkyl]-azaheterocyclamide compounds
11/05/2002	US6476264 N-(4-carbamimidoyl-phenyl)-glycine derivatives
11/05/2002	US6476052 Isoindolines, method of use, and pharmaceutical compositions
11/05/2002	US6476044 Use of morphine derivatives as medicaments for the treatment of neuropathic problems
11/05/2002	US6476038 Amino substituted pyrazolo[1,5,-a]-1,5-pyrimidines and pyrazolo[1,5-a]-1,3,5-triazines
11/05/2002	US6476031 Quinazoline derivatives as medicaments
11/05/2002	US6476029 7-alkyl- and cycloalkyl-substituted imidazotriazinones
11/05/2002	US6476023 Aromatic heterocyclic compounds as anti-inflammatory agents
11/05/2002	US6476016 Inhibiting loss of blood platelets, inhibiting formation of blood platelet aggregates, inhibiting formation of fibrin, inhibiting thrombus formation, and inhibiting embolus formation
11/05/2002	US6475988 Methods to increase white blood cell survival after chemotherapy
11/05/2002	US6475796 Vascular endothelial growth factor variants
11/05/2002	US6475493 Controlled release pellet formulation
11/05/2002	US6475480 Use of adenoviral E4 reading frames to improve expression of a gene of interest
11/05/2002	US6475182 Fluidic media introduction apparatus
11/05/2002	CA2205366C Meso-monoiodo-substituted tetramacrocyclic compounds and methods for making and using the same
11/05/2002	CA2147124C Erythropoietin analogs
11/05/2002	CA2038379C Trifluoromethyl mercaptan and mercaptoacyl derivatives and method of using same
10/2002
10/31/2002	WO2002086156A2 New polynucleotides and polypeptides of the ifn$g(a)-17 gene
10/31/2002	WO2002086078A2 Synthesis and evaluation of novel phthalimide mimics as anti-angiogenic agents
10/31/2002	WO2002086075A2 Methods and composition for the production of orthoganal trna-aminoacyltrna synthetase pairs
10/31/2002	WO2002086069A2 Secreted proteins
10/31/2002	WO2002085940A2 New polynucleotides and polypeptides of the erythropoietin gene
10/31/2002	WO2002085925A2 Melanocortin receptor ligands
10/31/2002	WO2002085923A2 In vivo incorporation of unnatural amino acids
10/31/2002	WO2002085906A2 Phthalazinones derivatives useful as pde4/7 inhibitors
10/31/2002	WO2002085899A1 Heterocyclyldicarbamides as caspase inhibitors
10/31/2002	WO2002085894A1 Arylindenopyridines with pde inhibiting activity
10/31/2002	WO2002085888A1 Tetrahydropyridyl-alkyl-heterocycles, method for preparing same and pharmaceutical compositions containing same
10/31/2002	WO2002085882A1 Coumarin derivatives to be used as anticoagulants
10/31/2002	WO2002085859A1 HETEROARYL UREAS CONTAINING NITROGEN HETERO-ATOMS AS p38 KINASE INHIBITORS
10/31/2002	WO2002085855A1 2-iminopyrrolidine derivatives
10/31/2002	WO2002085850A1 Cyclic amidine derivative
10/31/2002	WO2002085368A2 Use of radical scavenging compounds for treatment and prevention of no-dependent microcirculation disorders
10/31/2002	WO2002085364A1 Farnesyl protein transferase inhibitors for treating cachexia
10/31/2002	WO2002085361A1 Benzimidazolone compounds
10/31/2002	WO2002085357A1 Nociceptin analogs
10/31/2002	WO2002085356A1 1, 4, 5, 6-tetrahydropyrazolo-[3, 4-c]-pyrid in-7-ones as factor xa inhibitors
10/31/2002	WO2002085354A1 Spiroindene and spiroindane compounds
10/31/2002	WO2002085353A1 1,4,5,6-tetrahydropyrazolo-[3,4-c]-pyridin-7-ones as factor xa inhibitors
10/31/2002	WO2002085346A1 Use of creatine for the amelioration of oxidative stress
10/31/2002	WO2002085340A2 Oligonucleotide compositions and their use to induce differentiation of cells
10/31/2002	WO2002085124A1 Use of ppar-alpha-gamma ligands or agonists to prevent the rupture of atherosclerotic plaques
10/31/2002	WO2002085111A1 Flexible container system for storage of stabilized hemoglobin solutions
10/31/2002	WO2002068390A8 Diamides which inhibit tryptase and factor xa activity
10/31/2002	WO2002058750A3 A suspension comprising fibrinogen, thrombin and alcohol and a method of coating a carrier with the same
10/31/2002	WO2002049650A3 Pharmaceutical formulation containing thienopyrimidines and antithrombotics, calcium antagonists, prostaglandins or prostaglandin derivatives
10/31/2002	WO2002026720A3 PIPERAZINE BASED INHIBITORS OF FACTOR Xa
10/31/2002	WO2002022611A3 Caspase inhibitors and uses thereof
10/31/2002	WO2002004002A3 Use of strains of the parapox ovis virus for producing antiviral pharmaceuticals and anticancer pharmaceuticals
10/31/2002	WO2001087348A3 Multifunctional nanodevice platform
10/31/2002	WO2000062766A3 Uses of ppar-gamma agonists in neutrophil-induced diseases
10/31/2002	US20020161399 Compositions, systems, and methods for creating in situ, chemically cross-linked, mechanical barriers
10/31/2002	US20020161331 Indwelling heat exchange catheter and method of using same
10/31/2002	US20020161197 Defibrinating whole blood including red blood cells and a plasma component; filtering whole blood, whereby at least a portion of plasma is separated from red blood cells to form a red blood cell suspension, thereby purifying red blood cells
10/31/2002	US20020161024 Administering 2-(piperidin-2,6-dion-3-yl),4-amino-isoindolin-1-one to treat an eye condition
10/31/2002	US20020161014 Purinyl substituted quinazoline-4-one derivatives
10/31/2002	US20020161010 Treatment of various disorders associated with enhanced activity of kinase p38-alpha and/or transforming growth factor beta; antiinflammatory agents
10/31/2002	US20020161006 1,4-dihydropyridine compounds as bradykinin antagonists
10/31/2002	US20020160997 Novel indole derivatives
10/31/2002	US20020160987 Novel 4-dedimethylaminotetracycline derivatives
10/31/2002	US20020160974 Methods for treating autoimmune diseases in a subject and in vitro diagnostic assays
10/31/2002	US20020160963 Aminomethyl-pyrroloquinazoline compounds as thrombin receptor antagonists
10/31/2002	US20020160956 Pharmaceutical combination preparations containing erythropoietin and modified haemoglobins
10/31/2002	US20020160940 Modulation of endogenous gene expression in cells

1 ... 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 ... 671